In the last week, the Life Sciences industry is up 2.2%, with Locus Cell leading the way, up 14%. However, the industry is down 29% over the past year. As for the next few years, earnings are expected to grow by 147% per annum.
Has the Taiwanese Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 17 Apr 2024 | NT$40.1b | NT$2.1b | -NT$923,759,000.00 | 29.9x | -43.4x | 19x |
Fri, 15 Mar 2024 | NT$40.1b | NT$2.1b | -NT$611,249,000.00 | 32.2x | -65.6x | 19.5x |
Sun, 11 Feb 2024 | NT$43.0b | NT$2.1b | -NT$610,218,000.00 | 32.4x | -70.4x | 20.7x |
Tue, 09 Jan 2024 | NT$46.3b | NT$2.1b | -NT$610,218,000.00 | 34.1x | -75.9x | 22.3x |
Thu, 07 Dec 2023 | NT$48.3b | NT$2.1b | -NT$610,218,000.00 | 33.6x | -79.2x | 23.3x |
Sat, 04 Nov 2023 | NT$48.5b | NT$2.2b | -NT$497,769,000.00 | 31.8x | -97.4x | 21.8x |
Mon, 02 Oct 2023 | NT$48.0b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -96.4x | 21.6x |
Wed, 30 Aug 2023 | NT$43.4b | NT$2.2b | -NT$497,769,000.00 | 31x | -87.1x | 19.5x |
Fri, 28 Jul 2023 | NT$47.8b | NT$2.5b | -NT$274,767,000.00 | 42.9x | -173.9x | 19.5x |
Sun, 25 Jun 2023 | NT$48.4b | NT$2.5b | -NT$274,767,000.00 | 43.2x | -176.1x | 19.7x |
Tue, 23 May 2023 | NT$50.1b | NT$2.6b | -NT$38,534,000.00 | 42x | -1299.2x | 19.1x |
Thu, 20 Apr 2023 | NT$51.2b | NT$2.7b | -NT$29,761,000.00 | 24.7x | -1719.8x | 19.2x |
Sat, 18 Mar 2023 | NT$47.7b | NT$2.7b | NT$82.4m | 23.8x | 578.7x | 18x |
Mon, 13 Feb 2023 | NT$52.8b | NT$2.7b | NT$85.3m | 19.8x | 619x | 19.7x |
Wed, 11 Jan 2023 | NT$46.7b | NT$2.7b | NT$85.3m | 18.8x | 548.3x | 17.5x |
Fri, 09 Dec 2022 | NT$57.7b | NT$2.7b | NT$139.5m | 18.7x | 413.7x | 21.6x |
Sun, 06 Nov 2022 | NT$42.4b | NT$3.0b | NT$482.8m | 24.4x | 87.9x | 14.2x |
Tue, 04 Oct 2022 | NT$45.8b | NT$3.0b | NT$482.8m | 24x | 94.8x | 15.3x |
Thu, 01 Sep 2022 | NT$53.7b | NT$3.0b | NT$482.8m | 27.9x | 111.3x | 17.9x |
Sat, 30 Jul 2022 | NT$41.5b | NT$3.1b | NT$325.1m | 37.9x | 127.7x | 13.5x |
Mon, 27 Jun 2022 | NT$42.1b | NT$3.1b | NT$325.1m | 36.3x | 129.6x | 13.7x |
Wed, 25 May 2022 | NT$29.9b | NT$3.1b | NT$325.1m | 34.4x | 92x | 9.8x |
Fri, 22 Apr 2022 | NT$35.9b | NT$3.2b | NT$164.4m | 28.2x | 218.5x | 11.3x |
Sun, 20 Mar 2022 | NT$33.3b | NT$3.0b | -NT$115,919,000.00 | 25.2x | -286.9x | 10.9x |
Tue, 15 Feb 2022 | NT$35.9b | NT$3.0b | -NT$120,147,000.00 | 35.4x | -298.7x | 11.8x |
Thu, 13 Jan 2022 | NT$37.8b | NT$3.0b | -NT$120,147,000.00 | 35.4x | -314.3x | 12.4x |
Sat, 11 Dec 2021 | NT$39.4b | NT$3.0b | -NT$120,147,000.00 | 37.2x | -328.1x | 12.9x |
Mon, 08 Nov 2021 | NT$29.7b | NT$2.8b | -NT$510,835,000.00 | 23.1x | -58.2x | 10.6x |
Wed, 06 Oct 2021 | NT$31.5b | NT$2.3b | -NT$631,150,000.00 | 31.8x | -49.8x | 13.5x |
Fri, 03 Sep 2021 | NT$34.5b | NT$2.3b | -NT$631,150,000.00 | 32.1x | -54.7x | 14.8x |
Sun, 01 Aug 2021 | NT$35.9b | NT$2.3b | -NT$631,150,000.00 | 32.4x | -56.9x | 15.4x |
Wed, 05 May 2021 | NT$33.9b | NT$2.2b | -NT$810,177,000.00 | 29.2x | -41.8x | 15.6x |
-41.8x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | -3.71% | |
Healthcare | -2.13% | |
Life Sciences | -0.74% | |
Clinical Research and Equipment | -0.74% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6986 HeXun Biosciences | NT$70.00 | 14.0% +NT$395.6m | n/a | n/a | |
6939 TFBS Bioscience | NT$42.25 | 0.2% +NT$3.5m | n/a | n/a |